Evidence map›Paper›PMID 28826725›Full record

ArticleInternational journal of pharmaceutics2017

Dry powder aerosols to co-deliver antibiotics and nutrient dispersion compounds for enhanced bacterial biofilm eradication.

S Sommerfeld Ross, S Gharse, L Sanchez, J Fiegel

Abstract read
In one paragraph

Article in International journal of pharmaceutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Formulation of water-solubleFrontiers in pharmacology · 2022
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S Sommerfeld RossDepartment of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, 52242, USA.
S GharseDepartment of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, 52242, USA.
L SanchezDepartment of Chemistry, University of Iowa, Iowa City, IA, 52242, USA.
J FiegelDepartment of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, 52242, USA; Department of Chemical and Biochemical Engineering, University of Iowa, Iowa City, IA, 52242, USA. Electronic address: jennifer-fiegel@uiowa.edu.
University of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
UNIVERSITY OF IOWA CTSA FOR PEDIATRIC RESEARCHUL1RR024979 · NCRR · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2007 to 2011
$31.8M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNGS10RR022498 · NCRR · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2006 to 2006
$445k
Synergistic Drug Strategies Against Pseudomonas Aeruginosa BiofilmsR21AI096007 · NIAID · UNIVERSITY OF IOWA · PI FIEGEL, JENNIFER · 2013 to 2014
$406k
NCRR NIH HHS S10 RR022498NCRR NIH HHS UL1 RR024979NIAID NIH HHS R21 AI096007NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

The purpose of this study was to formulate a dry powder for inhalation containing a combination treatment for eradication of Pseudomonas aeruginosa bacterial biofilms. Dry powders containing an antibiotic (ciprofloxacin hydrochloride, CH) and nutrient dispersion compound (glutamic acid, GA) at a ratio determined to eliminate the biofilms were generated by spray drying. Leucine was added to the spray dried formulation to aid powder flowability. A central composite design of experiments was performed to determine the effects of solution and processing parameters on powder yield and aerodynamic properties. Combinations of CH and GA eradicated bacterial biofilms at lower antibiotic concentrations compared to CH alone. Spray dried powders were produced with yields up to 43% and mass mean aerodynamic diameters (MMAD) in the respirable range. Powder yield was primarily affected by variables that determine cyclone efficiency, i.e. atomizer and solution flow rates and solution concentration; while MMAD was mainly determined by solution concentration. Fine particle fractions (FPF)<4.46μm and <2.82μm of the powders ranged from 56 to 70% and 35 to 46%, respectively. This study demonstrates that dry powder aerosols containing high concentrations of a combination treatment effective against P. aeruginosa biofilms could be developed with high yield, aerodynamic properties appropriate for inhalation, and no loss of potency.

Indexed as

AerosolsPowdersAdministration, InhalationAnti-Bacterial AgentsBiofilmsChemistry, PharmaceuticalDry Powder InhalersParticle SizePseudomonas aeruginosaAerosolsAnti-Bacterial AgentsPowdersCentral composite designCiprofloxacinFine particle fractionMass median aerodynamic diameterPseudomonas aeruginosaSpray drying

Identifiers

PMID28826725
PMCPMC5597492
OpenAlexW2742279925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.